is semaglutide being banned π¨ FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these It's well past time to
Description
A peer-reviewed study in JMIR Formative Research found that active subscribers lost an average of 19.1% of their body weight at 12 months, with 77.7% achieving at least 10% weight loss

From a patient safety perspective, individuals should seek prompt medical advice if they experience: Severe or persistent abdominal pain (which may indicate pancreatitis) Right-upper-quadrant pain, fever, or jaundice (which may indicate a gallbladder problem) Rapid or irregular heartbeat Symptoms of hypoglycaemia, such as shakiness, sweating, or confusion Signs of an allergic reaction, such as rash, swelling, or difficulty breathing If you experience a suspected side effect from any medicine, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk

T.YinW.GarousiJ.GrslundT.et al (2024)

The little lines on your syringe are for units, and they help you measure tiny amounts of liquid perfectly

Dont settle for a one-size-fits-all approach when the future of health is highly individualized
Shima Hadidchi, MD , is committed to providing the latest, evidence-based treatments for weight management
